《大行報告》花旗下調南航(01055.HK)目標價至5.7元 評級「買入」
花旗發表報告,指南航(01055.HK)第三季度錄得淨虧損14億元人民幣,原因是區域性的新冠疫情反彈和燃油成本激增。儘管運輸量下降,今年第三季度收入仍按年增長2%,可能因較高收益率推動。展望未來,該行指仍然看好疫情後航空旅行需求的復甦,但目前仍然預計南航第四季淨虧損將按年擴大,因爲區域性的新冠確診重新出現和燃油價格激增。目標價由6.3元下調至至5.7元,評級「買入」。
花旗指,在中國航空股板塊中,南航是其短期首選,因爲集團在國內航線拓展大於同行,而且貨運業務具積極作用。至於長期首選仍然是國航(00753.HK),因爲一旦邊境重新開放,其盈利反彈的潛力較大,而且其國際航線的拓展高於同行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.